Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2010 5
2011 5
2012 4
2013 4
2014 16
2015 16
2016 21
2017 23
2018 23
2019 26
2020 36
2021 60
2022 57
2023 38
2024 35
2025 46
2026 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

376 results

Results by year

Filters applied: . Clear all
Page 1
Transcatheter Valve Replacement in Severe Tricuspid Regurgitation.
Hahn RT, Makkar R, Thourani VH, Makar M, Sharma RP, Haeffele C, Davidson CJ, Narang A, O'Neill B, Lee J, Yadav P, Zahr F, Chadderdon S, Eleid M, Pislaru S, Smith R, Szerlip M, Whisenant B, Sekaran NK, Garcia S, Stewart-Dehner T, Thiele H, Kipperman R, Koulogiannis K, Lim DS, Fowler D, Kapadia S, Harb SC, Grayburn PA, Sannino A, Mack MJ, Leon MB, Lurz P, Kodali SK; TRISCEND II Trial Investigators. Hahn RT, et al. N Engl J Med. 2025 Jan 9;392(2):115-126. doi: 10.1056/NEJMoa2401918. Epub 2024 Oct 30. N Engl J Med. 2025. PMID: 39475399 Clinical Trial.
Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus.
Herrmann HC, Mehran R, Blackman DJ, Bailey S, Möllmann H, Abdel-Wahab M, Ben Ali W, Mahoney PD, Ruge H, Wood DA, Bleiziffer S, Ramlawi B, Gada H, Petronio AS, Resor CD, Merhi W, Garcia Del Blanco B, Attizzani GF, Batchelor WB, Gillam LD, Guerrero M, Rogers T, Rovin JD, Szerlip M, Whisenant B, Deeb GM, Grubb KJ, Padang R, Fan MT, Althouse AD, Tchétché D; SMART Trial Investigators. Herrmann HC, et al. N Engl J Med. 2024 Jun 6;390(21):1959-1971. doi: 10.1056/NEJMoa2312573. Epub 2024 Apr 7. N Engl J Med. 2024. PMID: 38587261 Clinical Trial.
BACKGROUND: Patients with severe aortic stenosis and a small aortic annulus are at risk for impaired valvular hemodynamic performance and associated adverse cardiovascular clinical outcomes after transcatheter aortic-valve replacement (TAVR). METHODS: We randomly assigned …
BACKGROUND: Patients with severe aortic stenosis and a small aortic annulus are at risk for impaired valvular hemodynamic performance and as …
Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial.
Azizi M, Saxena M, Wang Y, Jenkins JS, Devireddy C, Rader F, Fisher NDL, Schmieder RE, Mahfoud F, Lindsey J, Sanghvi K, Todoran TM, Pacella J, Flack J, Daemen J, Sharp ASP, Lurz P, Bloch MJ, Weber MA, Lobo MD, Basile J, Claude L, Reeve-Stoffer H, McClure CK, Kirtane AJ; RADIANCE II Investigators and Collaborators. Azizi M, et al. JAMA. 2023 Feb 28;329(8):651-661. doi: 10.1001/jama.2023.0713. JAMA. 2023. PMID: 36853250 Free PMC article. Clinical Trial.
The primary safety composite outcome of major adverse events included death, kidney failure, and major embolic, vascular, cardiovascular, cerebrovascular, and hypertensive events at 30 days and renal artery stenosis greater than 70% detected at 6 months. ...
The primary safety composite outcome of major adverse events included death, kidney failure, and major embolic, vascular, cardiovascular …
Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement.
Kapadia SR, Makkar R, Leon M, Abdel-Wahab M, Waggoner T, Massberg S, Rottbauer W, Horr S, Sondergaard L, Karha J, Gooley R, Satler L, Stoler RC, Messé SR, Baron SJ, Seeger J, Kodali S, Krishnaswamy A, Thourani VH, Harrington K, Pocock S, Modolo R, Allocco DJ, Meredith IT, Linke A; PROTECTED TAVR Investigators. Kapadia SR, et al. Among authors: krishnaswamy a. N Engl J Med. 2022 Oct 6;387(14):1253-1263. doi: 10.1056/NEJMoa2204961. Epub 2022 Sep 17. N Engl J Med. 2022. PMID: 36121045 Clinical Trial.
Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial.
Yeh RW, Shlofmitz R, Moses J, Bachinsky W, Dohad S, Rudick S, Stoler R, Jefferson BK, Nicholson W, Altman J, Bateman C, Krishnaswamy A, Grantham JA, Zidar FJ, Marso SP, Tremmel JA, Grines C, Ahmed MI, Latib A, Tehrani B, Abbott JD, Batchelor W, Underwood P, Allocco DJ, Kirtane AJ; AGENT IDE Investigators. Yeh RW, et al. Among authors: krishnaswamy a. JAMA. 2024 Mar 26;331(12):1015-1024. doi: 10.1001/jama.2024.1361. JAMA. 2024. PMID: 38460161 Free PMC article.
Clinical cerebrovascular anatomy.
Krishnaswamy A, Klein JP, Kapadia SR. Krishnaswamy A, et al. Catheter Cardiovasc Interv. 2010 Mar 1;75(4):530-9. doi: 10.1002/ccd.22299. Catheter Cardiovasc Interv. 2010. PMID: 20049963 Review.
Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study.
Makkar RR, Thourani VH, Vahl TP, Yadav PK, McCabe JM, George I, Satler L, Chetcuti S, Daniels DV, Waggoner T, Whisenant B, Russo M, Summers M, Garcia S, Frisoli T, Ramana RK, Stinis C, Golwala H, Zahr F, Greenbaum A, Rovin J, Sanchez C, Szerlip M, Deeb GM, Amoroso N, Patel D, Fahy M, Ranard LS, Gupta A, Chakravarty T, Skaf S, Chuang M, Kodali SK, Figulla HR, Treede H, Baldus S, Pinto DS, Leon MB; ALIGN-AR Investigators. Makkar RR, et al. Lancet. 2025 Dec 13;406(10521):2757-2771. doi: 10.1016/S0140-6736(25)02215-9. Epub 2025 Nov 16. Lancet. 2025. PMID: 41260228 Clinical Trial.
Pacemaker Implantation After TAVR.
Kapadia SR, Wazni O, Krishnaswamy A. Kapadia SR, et al. Among authors: krishnaswamy a. JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt A):1148-1150. doi: 10.1016/j.jcmg.2016.09.032. Epub 2017 Apr 12. JACC Cardiovasc Imaging. 2017. PMID: 28412418 Free article. No abstract available.
Frailty Predicts Geriatric and Cardiovascular Adverse Outcomes After TAVR: A 5-Year Real-World Analysis.
Badwan O, Motairek I, Zghyer F, Puri R, Reed G, Krishnaswamy A, Menon V, Damluji AA, Kapadia S. Badwan O, et al. Among authors: krishnaswamy a. JACC Adv. 2025 Dec;4(12 Pt 1):102326. doi: 10.1016/j.jacadv.2025.102326. Epub 2025 Nov 19. JACC Adv. 2025. PMID: 41263744 Free PMC article.
The primary outcome was 5-year all-cause mortality. Secondary outcomes included cardiovascular events, procedural complications, and geriatric syndromes. Analyses were stratified by age groups: <65, 65 to 75, and >75 years. ...
The primary outcome was 5-year all-cause mortality. Secondary outcomes included cardiovascular events, procedural complications, and …
376 results